Figure 3.
(a–f) CT of the patient throughout treatment with crizotinib, alectinib, and lorlatinib demonstrated decreasing diameters of abdominal and pelvic lesions (white arrows) and accumulated fluid (black arrows).
CT, computed tomography.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.